Clinical Trial Update: A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of an estradiol vaginal capsule in postmenopausal women with vulvovaginal atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• Estradiol Vaginal Capsule (estradiol)

Snippet

Sponsor: Warner Chilcott | Conditions: Vulvovaginal Atrophy, Menopause | Phase 2 | Status: COMPLETED